the exact mode of action of mersacidin and its variants, as
well as developing novel analogues with increased efficacy,
we have embarked on the total synthesis of 1.
olefins have appeared.18À21 Yet, despite its simplicity, this
approach is hampered the need for strongly basic condi-
tions, which may not be suitable for all substrates. In
addition, these methods may also require access to activated
and/or stereodefined olefins.
Given our recent report of the concise synthesis of
orthogonally protected β-MeCys and β-MeLan,22 we en-
visioned the direct synthesis of this AviMeCys unit via
decarbonylation of an activated lanthionine precursor
(Scheme 1). In our efforts toward the chemical synthesis
of mersacidin, we now wish to report our advances in this
area, specifically the expeditious synthesis of the Avi-
MeCys unit directly from the β-MeLan unit.23
The presence of the sensitive S-[(Z)-2-aminovinyl]-3-
methyl-D-cysteine (AviMeCys) linkage in the CD ring
system, as well as the unnatural amino acid (2S,3S)-
β-methylcysteine (β-MeCys) and (2S,3S,6R)-β-methyl-
lanthionine (β-MeLan) fragments in the A, B, and CD
ring systems, renders mersacidin a challenging synthetic
target. The AviMeCys subunit is present in other bio-
active peptides including epidermin,4 thioviridamide,5
and the recently discovered microbisporicin, now con-
sidered the most potent lantibiotic to date.6 Still, at the
time we initiated our studies, no synthesis of the Avi-
MeCys functionality had been reported.7
Although little is known about the function of the
enamide subunit, it appears to have a critical role for the
biological activity of other agents.8,9 As a result, a wide
range of methodologies has arisen to address the issues of
chemo- and stereoselectivity associated with their chemical
synthesis. Given that enamides possess intrinsically mod-
erate reactivity, they may also serve as intermediates for
accessing other functionality.10,11
The concept of a decarbonylative pathway to enamides
is not novel, although its documentation is limited,24À26
probably because it has traditionally been viewed as an
undesirable side reaction. As a result, we took a systematic
approach for optimization of this strategy.27
Our initial approach consisted of evaluating amino acid
chlorides in light of Bubner’s observation that an enamide
byproduct was isolated during the attempted Stille cross-
coupling of Fmoc-Pro-Cl.24,28 Like Bubner, we also ob-
served the lack of enamide formation in the absence of
an organostannane. In search of additives that could
enhance reactivity, we found that nBu4I was very efficient
at promoting the catalytic decarbonylation of Fmoc-
Pro-Cl, while only traces of the desired product were
observed with NaI, presumably an artifact of its low
solubility in organic solvents. The efficiency of this process
is highlighted by the observation that Fmoc-Pro-OH could
be activated in situ with diphenylphosphoryl chloride to
give high yields of the pyrroline product. Unfortunately,
when these conditions were applied to the synthesis of
cysteine-derived enamides, only the enamine byproduct
arising from β-elimination (i.e., desulfurization) was ob-
served. CuI was added in an effort to sequester thiol
byproducts and suppress the potential for poisoning of
the Pd catalyst. However, this only increased the amount
of the elimination byproduct that was generated. Further-
more, only decomposition was observed in the attempted
decarbonylation of Fmoc-Ser(OBn)-Cl and Fmoc-Val-Cl.
Scheme 1. Retrosynthetic Analysis of the Enamide Unit
Methods that have been developed for the synthesis of
enamides include the Curtius rearrangement,12 Peterson
olefination,13 vinyl transfer,14 hydrometalation of alkynes,15
radical decarboxylation,16 and radical addition to ynamides.17
Most recently, several reports of transition-metal-catalyzed
cross-coupling reactions between amides and activated
€
(4) Allgaier, H.; Jung, G.; Werner, R. G.; Schneider, U.; Zahner, H.
Angew. Chem., Int. Ed. 1985, 24, 1051.
(5) Hayakawa, Y.; Sasaki, K.; Adachi, H.; Furihata, K.; Nagai, K.;
(18) Dehli, J. R.; Legros, J.; Bolm, C. Chem. Commun. 2005, 973.
(19) Wallace, D. J.; Klauber, D. J.; Chen, C.-y.; Volante, R. P. Org.
Lett. 2003, 5, 4749.
(20) Cesati, R. R.; Dwyer, G.;Jones, R. C.; Hayes, M. P.;Yalamanchili,
P.; Casebier, D. S. Org. Lett. 2007, 9, 5617.
(21) Yuri, B.; Robert, A. B. Angew. Chem. 2008, 120, 2139.
(22) Narayan, R. S.; VanNieuwenhze, M. S. Org. Lett. 2005, 7,
2655.
(23) For a review on recent developments in lantibiotic synthesis, see:
Tabor, A. B. Org. Biomol. Chem. 2011, 9, 7606–7628.
(24) Crisp, G. T.; Bubner, T. P. Synth. Commun. 1990, 20, 1665.
(25) Goto, T.; Onaka, M.; Mukaiyama, T. Chem. Lett. 1980, Vol.9
709.
Shin-ya, K. J. Antibiot. 2006, 59, 1.
(6) Castiglione, F.; Lazzarini, A.; Carrano, L.; Corti, E.; Ciciliato, I.;
Gastaldo, L.; Candiani, P.; Losi, D.; Marinelli, F.; Selva, E.; Parenti, F.
Chem. Biol. 2008, 15, 22.
(7) For a recent review of AviCys-containing lantibiotics, see: Sit,
C. S.; Yoganathan, S.; Vederas, J. C. Acc. Chem. Res. 2011, 44, 261–268.
(8) Yet, L. Chem. Rev. 2003, 103, 4283.
(9) Wu, Y.; Liao, X.; Wang, R.; Xie, X.-S.; De Brabander, J. K. J.
Am. Chem. Soc. 2002, 124, 3245.
(10) Carbery, D. R. Org. Biomol. Chem. 2008, 6, 3455.
(11) Matsubara, R.; Kobayashi, S. Acc. Chem. Res. 2008, 41, 292.
(12) Kuramochi, K.;Osada, Y.; Kitahara, T. Tetrahedron 2003, 59, 9447.
(13) Furstner, A.; Brehm, C.; Cancho-Grande, Y. Org. Lett. 2001, 3,
3955.
(26) Yang, H.; Li, H.; Wittenberg, R.; Egi, M.; Huang, W.; Liebeskind,
L. S. J. Am. Chem. Soc. 2007, 129, 1132.
ꢀ
(27) Min, G. K.; Hernandez, D.; Lindhardt, A. T.; Skrysdstrup, T.
Org. Lett. 2010, 12, 4716–4719.
(14) Brice, J. L.; Meerdink, J. E.; Stahl, S. S. Org. Lett. 2004, 6, 1845.
(15) Buissonneaud, D.; Cintrat, J.-C. Tetrahedron Lett. 2006, 47,
3139.
(16) Wang, X.; Porco, J. A. J. Org. Chem. 2001, 66, 8215.
(17) Banerjee, B.; Litvinov, D. N.; Kang, J.; Bettale, J. D.; Castle,
S. L. Org. Lett. 2010, 12, 2650.
(28) We note that ref 27, highlighting a qualitatively analogous
approach using Pd catalysis, appeared during the course of our study.
Our method requires lower reaction temperatures (rt with most Ni
catalyst systems) and utilized simple phosphine ligands. In addition,
we also observed the desired (Z)-selectivity for cysteine- and serine-
based substrates in contrast to the results reported in ref 27.
Org. Lett., Vol. 14, No. 4, 2012
1031